Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ
about
Current view on ductal carcinoma in situ and importance of the margin thresholds: A reviewThe utility of linked cancer registry and health administration data for describing system-wide outcomes and research: a BreastScreen example.A comparison of the risks of in-breast recurrence after a diagnosis of dcis or early invasive breast cancerRacial disparities in risk of second breast tumors after ductal carcinoma in situ.Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the communityPredictors for local invasive recurrence of ductal carcinoma in situ of the breast: a meta-analysisBreast conserving therapy for DCIS--does size matter?Disparities in breast cancer and african ancestry: a global perspective.Comparing treatment and outcomes of ductal carcinoma in situ among women in Missouri by race.Mammographic extent of microcalcifications and oestrogen receptor expression affect preoperative breast carcinoma in situ size estimation.The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy.Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients.Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery.Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
P2860
Q26853548-2D16C919-1824-49C4-A808-08FB6541BB77Q31061505-C644AB38-C2DF-4673-AC4C-591A6E4D57F1Q33763855-7A379FEB-A392-4C2B-9D6D-DA6795C43BFDQ35282266-9F9CC015-D9FE-430D-B46D-F5F09F27F93FQ36131718-95B84AB1-00E2-4ED5-A21A-BC18B50209E7Q36412499-C6ED1047-4A57-444E-A1EC-0BFB68787941Q36619677-1B82E4E1-40DE-407B-9563-F61236E772E5Q36947855-A08FB4A5-6A91-4F2D-BF19-56F733E2F44BQ38214868-889A700A-1A48-46FE-9C64-4ECB38AD2810Q38339360-E42D2003-5A58-4037-BC1F-8156548D1426Q38800781-9834D167-24D7-4B39-8374-B3B95DA9A885Q38957691-275E12AE-54A5-4CDB-A104-DA6976A6DEEDQ39201898-6A7CBF63-D66A-4282-B96E-A02EE489F640Q40832706-875EDEB1-C478-4D2F-9566-A49D487319D2Q46124060-3705C841-8E4E-47AA-887C-BEFEA8E084B5Q46200816-EB6E8759-9B81-41DA-9B1D-E477F99AEE5F
P2860
Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Risk factors for non-invasive ...... with ductal carcinoma in situ
@ast
Risk factors for non-invasive ...... with ductal carcinoma in situ
@en
type
label
Risk factors for non-invasive ...... with ductal carcinoma in situ
@ast
Risk factors for non-invasive ...... with ductal carcinoma in situ
@en
prefLabel
Risk factors for non-invasive ...... with ductal carcinoma in situ
@ast
Risk factors for non-invasive ...... with ductal carcinoma in situ
@en
P2093
P2860
P1476
Risk factors for non-invasive ...... with ductal carcinoma in situ
@en
P2093
Charles P Quesenberry
Larissa Nekhlyudov
Laura C Collins
Ninah Achacoso
Reina Haque
Stuart J Schnitt
Suzanne W Fletcher
P2860
P2888
P304
P356
10.1007/S10549-013-2539-5
P407
P577
2013-04-27T00:00:00Z
P6179
1041395919